Knowledge as an Asset in Pharmaceuticals

This week, Stacey is joined by Marty Lipa, Executive Director Knowledge Management, Merck & Co. Stacey and Marty discuss the importance of “managing knowledge as an asset” in the pharmaceutical industry and learn how every company can begin to capitalize on this very important product.

1. Link to ICH Q10: https://database.ich.org/sites/default/files/Q10%20Guideline.pdf

2. Link to find out more about the Knowledge Transfer Enhancement Framework (Chapter 6): https://arrow.tudublin.ie/cgi/viewcontent.cgi?article=1011&context=ditpress

3. Effective Knowledge Transfer During Biopharmaceutical Technology Transfer: https://www.ivtnetwork.com/article/effective-knowledge-transfer-during-biopharmaceutical-technology-transfer

4. Managing Knowledge and Risk – A Literature Review on the Interdependency of QRM and KM as ICH Q10 Enablers: https://www.ivtnetwork.com/article/managing-knowledge-and-risk-%E2%80%93-literature-review-interdependency-qrm-and-km-ich-q10-enablers

Marty has over 25 years’ industry experience and 12 years’ experience in Knowledge Management. He has published several industry specific works and is currently pursuing his Ph.D. at Technological University Dublin in Pharmaceutical and Regulatory Science with an emphasis on Knowledge Management. Lipa also leads the Knowledge Management Center of Excellence for the Manufacturing Division of Merck & Co., Inc.

Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.